Vanguard Fiduciary Trust
CRDF icon

Vanguard Fiduciary Trust’s Cardiff Oncology CRDF Stock Holding History

Vanguard Fiduciary Trust’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$534K Sell
410,602
-35,623
-8% -$56.6K ﹤0.01% 3248
2026
Q1 		$723K Buy
+446,225
New +$916K ﹤0.01% 3065

Other funds holding CRDF

LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Fiduciary Trust's CRDF Position: Q2 2026 in Review

Vanguard Fiduciary Trust reduced its Cardiff Oncology (CRDF) stake by 8% in Q2 2026, selling an estimated $56.6K and leaving 410,602 shares worth $534K. The position accounts for ﹤0.01% of the portfolio, ranked #3248.

Vanguard Fiduciary Trust first reported a position in CRDF in Q1 2026 and has held it in 2 quarters since. The position peaked at $723K in Q1 2026. 104 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.

  • Vanguard Fiduciary Trust held 410,602 shares of Cardiff Oncology worth $534K as of Q2 2026.
  • Vanguard Fiduciary Trust sold 35,623 Cardiff Oncology shares in Q2 2026, an estimated $56.6K.
  • Cardiff Oncology made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3248 holding.
  • Vanguard Fiduciary Trust first reported a position in Cardiff Oncology in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Cardiff Oncology position peaked at $723K in Q1 2026.
  • 104 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.